APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyprogesterone Caproate Injection

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Selected research

Market Structure

Global Hydroxyprogesterone Caproate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025185 pages

Choose your research edition.

Industry ResearchHydroxyprogesterone Caproate Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyprogesterone Caproate Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Hydroxyprogesterone Caproate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyprogesterone Caproate Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyprogesterone Caproate Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

This report provides an overview of the global Hydroxyprogesterone Caproate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hydroxyprogesterone Caproate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxyprogesterone Caproate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxyprogesterone Caproate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxyprogesterone Caproate Injection Segment by Company

AMAG Pharmaceuticals

Mcguff Pharmaceuticals Inc

Aspen Oss B.V

American Regent, Inc.

Mylan Institutional

Hydroxyprogesterone Caproate Injection Segment by Type

1 mL Injection(Including 1.1 mL)

5 mL Injection

Hydroxyprogesterone Caproate Injection Segment by Application

Hospitals Injection

Clinics Injection

Hydroxyprogesterone Caproate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxyprogesterone Caproate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxyprogesterone Caproate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxyprogesterone Caproate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxyprogesterone Caproate Injection Industry Trends Table 2. Hydroxyprogesterone Caproate Injection Industry Drivers Table 3. Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges Table 4. Hydroxyprogesterone Caproate Injection Industry Restraints Table 5. Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers Table 9. Global Hydroxyprogesterone Caproate Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hydroxyprogesterone Caproate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxyprogesterone Caproate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxyprogesterone Caproate Injection Manufacturers, Product Type & Application Table 13. Global Hydroxyprogesterone Caproate Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxyprogesterone Caproate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1 mL Injection(Including 1.1 mL) Table 17. Major Manufacturers of 5 mL Injection Table 18. Global Hydroxyprogesterone Caproate Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021-2026) Table 22. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2027-2032) Table 23. Global Hydroxyprogesterone Caproate Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021-2026) Table 27. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Injection Table 29. Major Manufacturers of Clinics Injection Table 30. Global Hydroxyprogesterone Caproate Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 32. Global Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 33. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021-2026) Table 34. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2027-2032) Table 35. Global Hydroxyprogesterone Caproate Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (K Units) Table 37. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (K Units) Table 38. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021-2026) Table 39. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2027-2032) Table 40. Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021-2026) Table 43. Global Hydroxyprogesterone Caproate Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Hydroxyprogesterone Caproate Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 47. North America Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 48. Europe Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 50. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 57. Global Hydroxyprogesterone Caproate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021-2026) Table 61. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2027-2032) Table 62. AMAG Pharmaceuticals Company Information Table 63. AMAG Pharmaceuticals Business Overview Table 64. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio Table 66. AMAG Pharmaceuticals Recent Development Table 67. Mcguff Pharmaceuticals Inc Company Information Table 68. Mcguff Pharmaceuticals Inc Business Overview Table 69. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio Table 71. Mcguff Pharmaceuticals Inc Recent Development Table 72. Aspen Oss B.V Company Information Table 73. Aspen Oss B.V Business Overview Table 74. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio Table 76. Aspen Oss B.V Recent Development Table 77. American Regent, Inc. Company Information Table 78. American Regent, Inc. Business Overview Table 79. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio Table 81. American Regent, Inc. Recent Development Table 82. Mylan Institutional Company Information Table 83. Mylan Institutional Business Overview Table 84. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio Table 86. Mylan Institutional Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Hydroxyprogesterone Caproate Injection Distributors List Table 90. Hydroxyprogesterone Caproate Injection Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Hydroxyprogesterone Caproate Injection Product Image Figure 2. Global Hydroxyprogesterone Caproate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyprogesterone Caproate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxyprogesterone Caproate Injection Sales (2021-2032) & (K Units) Figure 5. Global Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxyprogesterone Caproate Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1 mL Injection(Including 1.1 mL) Image Figure 9. 5 mL Injection Image Figure 10. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hydroxyprogesterone Caproate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021-2032) Figure 13. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hydroxyprogesterone Caproate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Injection Image Figure 17. Clinics Injection Image Figure 18. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Hydroxyprogesterone Caproate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021-2032) Figure 21. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Hydroxyprogesterone Caproate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2032) Figure 38. China Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Hydroxyprogesterone Caproate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Hydroxyprogesterone Caproate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hydroxyprogesterone Caproate Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hydroxyprogesterone Caproate Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
Applications
  • Hospitals Injection
  • Clinics Injection
Companies covered
  • AMAG Pharmaceuticals
  • Mcguff Pharmaceuticals Inc
  • Aspen Oss B.V
  • American Regent, Inc.
  • Mylan Institutional

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxyprogesterone Caproate Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxyprogesterone Caproate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxyprogesterone Caproate Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxyprogesterone Caproate Injection Market Dynamics
  1. 2.1 Hydroxyprogesterone Caproate Injection Industry Trends
  2. 2.2 Hydroxyprogesterone Caproate Injection Industry Drivers
  3. 2.3 Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges
  4. 2.4 Hydroxyprogesterone Caproate Injection Industry Restraints
3 Hydroxyprogesterone Caproate Injection Market by Manufacturers
  1. 3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxyprogesterone Caproate Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxyprogesterone Caproate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxyprogesterone Caproate Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxyprogesterone Caproate Injection Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxyprogesterone Caproate Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxyprogesterone Caproate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxyprogesterone Caproate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxyprogesterone Caproate Injection Tier 1, Tier 2, and Tier 3
4 Hydroxyprogesterone Caproate Injection Market by Type
  1. 4.1 Hydroxyprogesterone Caproate Injection Type Introduction
  2. 4.1.1 1 mL Injection(Including 1.1 mL)
  3. 4.1.2 5 mL Injection
  4. 4.2 Global Hydroxyprogesterone Caproate Injection Sales by Type
  5. 4.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hydroxyprogesterone Caproate Injection Revenue by Type
  9. 4.3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021-2032)
5 Hydroxyprogesterone Caproate Injection Market by Application
  1. 5.1 Hydroxyprogesterone Caproate Injection Application Introduction
  2. 5.1.1 Hospitals Injection
  3. 5.1.2 Clinics Injection
  4. 5.2 Global Hydroxyprogesterone Caproate Injection Sales by Application
  5. 5.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hydroxyprogesterone Caproate Injection Revenue by Application
  9. 5.3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021-2032)
6 Global Hydroxyprogesterone Caproate Injection Sales by Region
  1. 6.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxyprogesterone Caproate Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxyprogesterone Caproate Injection Revenue by Region
  1. 7.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region
  2. 7.1.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxyprogesterone Caproate Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxyprogesterone Caproate Injection Revenue (2021-2032)
  8. 7.2.2 North America Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxyprogesterone Caproate Injection Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AMAG Pharmaceuticals
  2. 8.1.1 AMAG Pharmaceuticals Company Information
  3. 8.1.2 AMAG Pharmaceuticals Business Overview
  4. 8.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
  6. 8.1.5 AMAG Pharmaceuticals Recent Developments
  7. 8.2 Mcguff Pharmaceuticals Inc
  8. 8.2.1 Mcguff Pharmaceuticals Inc Company Information
  9. 8.2.2 Mcguff Pharmaceuticals Inc Business Overview
  10. 8.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
  12. 8.2.5 Mcguff Pharmaceuticals Inc Recent Developments
  13. 8.3 Aspen Oss B.V
  14. 8.3.1 Aspen Oss B.V Company Information
  15. 8.3.2 Aspen Oss B.V Business Overview
  16. 8.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
  18. 8.3.5 Aspen Oss B.V Recent Developments
  19. 8.4 American Regent, Inc.
  20. 8.4.1 American Regent, Inc. Company Information
  21. 8.4.2 American Regent, Inc. Business Overview
  22. 8.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
  24. 8.4.5 American Regent, Inc. Recent Developments
  25. 8.5 Mylan Institutional
  26. 8.5.1 Mylan Institutional Company Information
  27. 8.5.2 Mylan Institutional Business Overview
  28. 8.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
  30. 8.5.5 Mylan Institutional Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxyprogesterone Caproate Injection Value Chain Analysis
  2. 9.1.1 Hydroxyprogesterone Caproate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxyprogesterone Caproate Injection Production Mode & Process
  6. 9.2 Hydroxyprogesterone Caproate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxyprogesterone Caproate Injection Distributors
  9. 9.2.3 Hydroxyprogesterone Caproate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst